Glen Eagle Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$66.2K Sell
126
-10
-7% -$5.25K 0.01% 377
2025
Q1
$86.3K Hold
136
0.01% 328
2024
Q4
$96.9K Hold
136
0.02% 311
2024
Q3
$143K Hold
136
0.02% 275
2024
Q2
$143K Buy
136
+10
+8% +$10.5K 0.03% 263
2024
Q1
$121K Sell
126
-2
-2% -$1.93K 0.02% 284
2023
Q4
$112K Hold
128
0.02% 284
2023
Q3
$105K Hold
128
0.02% 286
2023
Q2
$92K Hold
128
0.02% 298
2023
Q1
$105K Sell
128
-1
-0.8% -$822 0.03% 278
2022
Q4
$93.1K Buy
129
+1
+0.8% +$721 0.03% 286
2022
Q3
$88.2K Sell
128
-8
-6% -$5.51K 0.03% 278
2022
Q2
$80.4K Hold
136
0.02% 305
2022
Q1
$95K Hold
136
0.02% 288
2021
Q4
$85.9K Hold
136
0.02% 301
2021
Q3
$82.3K Sell
136
-5
-4% -$3.03K 0.02% 300
2021
Q2
$78.8K Sell
141
-60
-30% -$33.5K 0.02% 303
2021
Q1
$95.1K Sell
201
-50
-20% -$23.7K 0.03% 258
2020
Q4
$121K Sell
251
-9
-3% -$4.35K 0.05% 213
2020
Q3
$146K Hold
260
0.07% 183
2020
Q2
$162K Buy
260
+108
+71% +$67.4K 0.08% 167
2020
Q1
$74.2K Buy
152
+107
+238% +$52.2K 0.05% 223
2019
Q4
$16.9K Hold
45
0.01% 491
2019
Q3
$12.5K Hold
45
0.01% 475
2019
Q2
$14.1K Hold
45
0.01% 450
2019
Q1
$18.5K Hold
45
0.01% 394
2018
Q4
$16.8K Hold
45
0.01% 386
2018
Q3
$18.2K Hold
45
0.01% 392
2018
Q2
$15.5K Hold
45
0.01% 394
2018
Q1
$15.5K Hold
45
0.01% 373
2017
Q4
$16.9K Hold
45
0.01% 359
2017
Q3
$20.1K Hold
45
0.02% 334
2017
Q2
$22.1K Hold
45
0.02% 298
2017
Q1
$17.4K Hold
45
0.01% 301
2016
Q4
$16.5K Buy
+45
New +$16.5K 0.01% 292